MARKET

COLL

COLL

Collegium Pharmaceutical Inc
NASDAQ
34.62
+1.17
+3.50%
Closed 16:10 06/23 EDT
OPEN
33.92
PREV CLOSE
33.45
HIGH
34.87
LOW
33.79
VOLUME
317.95K
TURNOVER
0
52 WEEK HIGH
50.79
52 WEEK LOW
29.19
MARKET CAP
1.12B
P/E (TTM)
17.00
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at COLL last week (0615-0619)?
Weekly Report · 2d ago
Did Collegium Pharmaceutical’s Profitability Surge and Efficiency Gains Just Shift COLL’s Investment Narrative?
Simply Wall St · 3d ago
As U.S. profit margins near record highs, these small-cap stocks lead on profitability
Seeking Alpha · 6d ago
Weekly Report: what happened at COLL last week (0608-0612)?
Weekly Report · 06/15 09:53
Weekly Report: what happened at COLL last week (0601-0605)?
Weekly Report · 06/08 09:50
Collegium Pharmaceutical awards 50,305 RSUs to 34 newly hired employees under inducement plan
PUBT · 06/05 12:00
COLLEGIUM PHARMACEUTICAL REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 06/05 12:00
Weekly Report: what happened at COLL last week (0525-0529)?
Weekly Report · 06/01 09:53
More
About COLL
Collegium Pharmaceutical, Inc. is a diversified biopharmaceutical company. The Company has developed, licensed, and acquired a portfolio of products for use in the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. Its commercial products include Jornay PM (Jornay), Belbuca, Xtampza ER (Xtampza), Nucynta ER and Nucynta IR (Nucynta Products), and Symproic in the United States. Its Jornay is a central nervous system (CNS) stimulant prescription medicine for the treatment of ADHD. The Belbuca is a buccal film that contains buprenorphine for severe and persistent pain. Xtampza ER is an abuse-deterrent, extended-release, oral formulation of oxycodone. The Xtampza ER is a pain treatment option designed with abuse deterrent properties. Its portfolio also includes AZSTARYS (serdexmethylphenidate and dexmethylphenidate), a central nervous system (CNS) stimulant prescription medicine used for the treatment of ADHD in people six years of age and older.

Webull offers Collegium Pharmaceutical Inc stock information, including NASDAQ: COLL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, COLL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading COLL stock methods without spending real money on the virtual paper trading platform.